Management of vyanga (melasma) through raktachandanadi lepa

An open labelled single arm prospective clinical trial to evaluate the efficacy of raktachandanadi lepa in vyanga w.s.r. to melasma - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080706

Enrollment

Registered

2025-02-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L819- Disorder of pigmentation, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with the classical signs of melasma(vyanga) according to ayurveda and modern text. 2. Brown patches present only on face region. 3. Chronicity less than 3 years. 4. Patients fulfilling the diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. Inflammatory pigmentation, malignant melanoma, Acne Vulgaris. 2. Painful and hard lesions. 3. Patches on neck and upper chest. 4. Patients on certain medications(OCP, HTN) 5. Patients having vyanga since birth(Nevus of OTA)

Design outcomes

Primary

Measure	Time frame
Improvement in subjective parameters like shyava, niruja and tanu mandala on mukha.Timepoint: from 0 to 21 days	—

Secondary

Measure	Time frame
To assess the effect of trial drugs in improving the signs and symptoms as per assessment criteria and MASI score.Timepoint: After 21 days	—

Countries

India

Contacts

Public ContactDr Vivek Shrivastava

Govt. Ayurveda College Rewa

dr.pravanjan@gmail.com9827459956

Outcome results